HM Payson & Co’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $463 | Hold |
65
| – | – | ﹤0.01% | 1014 |
|
|
2024
Q4 | $758 | Hold |
65
| – | – | ﹤0.01% | 1003 |
|
|
2024
Q3 | $1.34K | Hold |
65
| – | – | ﹤0.01% | 1004 |
|
|
2024
Q2 | $1.46K | Hold |
65
| – | – | ﹤0.01% | 939 |
|
|
2024
Q1 | $1.79K | Hold |
65
| – | – | ﹤0.01% | 905 |
|
|
2023
Q4 | $1.98K | Hold |
65
| – | – | ﹤0.01% | 904 |
|
|
2023
Q3 | $2.06K | Hold |
65
| – | – | ﹤0.01% | 930 |
|
|
2023
Q2 | $2.65K | Hold |
65
| – | – | ﹤0.01% | 898 |
|
|
2023
Q1 | $2.42K | Hold |
65
| – | – | ﹤0.01% | 910 |
|
|
2022
Q4 | $2.27K | Hold |
65
| – | – | ﹤0.01% | 849 |
|
|
2022
Q3 | $4K | Hold |
65
| – | – | ﹤0.01% | 869 |
|
|
2022
Q2 | $3K | Hold |
65
| – | – | ﹤0.01% | 931 |
|
|
2022
Q1 | $5K | Hold |
65
| – | – | ﹤0.01% | 915 |
|
|
2021
Q4 | $8K | Hold |
65
| – | – | ﹤0.01% | 898 |
|
|
2021
Q3 | $9K | Buy |
+65
| New | +$9K | ﹤0.01% | 846 |
|